Data Foundry

Drug recalls 2016

Betamethasone Acetate / Betamethasone Sodium Phosphate Injectable… — Class II drug recall D-1454-2016

Terminated recall by Isomeric Pharmacy Solution, LLC, reported 2016-08-10, distributed nationwide. Lack of processing controls: Isomeric Pharmacy Solution, LLC is recalling Betamethasone Acetate / Betamethason

Recall numberD-1454-2016
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmIsomeric Pharmacy Solution, LLC, Salt Lake City, UT, United States
Recall initiated2016-08-01
Classified2016-08-04
Reported by FDA2016-08-10
Terminated2017-08-01
DistributedNationwide (US)
Quantity2,331 vials
Reason classessterility
Lot numbers03037, 03042, 03043, 04043, 04047, 04048, 04052, 04053, 05042, 05046, 05048, 05049, 05050
Expiration dates2016-08-17, 2016-08-31, 2016-09-29, 2016-10-01, 2016-10-02, 2016-10-29, 2016-11-02, 2016-11-03, 2016-11-04

Product

Betamethasone Acetate / Betamethasone Sodium Phosphate Injectable Suspension, 7 mg/ mL,10 mL Multi-Dose vial for injection, Rx Only, Isomeric Pharmacy Solution, 2401 Foothill Dr., Salt Lake City, UT 84109

Reason for recall

Lack of processing controls: Isomeric Pharmacy Solution, LLC is recalling Betamethasone Acetate / Betamethasone Sodium Phosphate 7 mg/mL INJ SUSP because of the potential of drug clumps in the vial of the sterile drug product and larger particle sizes.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1454-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.